SCHEMBL3403368

SCHEMBL3403368

Cc1nc(-c2ccc(C(C)C)cc2)sc1C(=O)N1CCC(N2CCCCC2)CC1

nearest known ligand 0.52

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 5/20 0.52
CNR1 P21554 1/20 0.49
THRA P10827 2/20 0.48
THRB P10828 2/20 0.48
HTR2C P28335 3/20 0.47
OXTR P30559 1/20 0.47
L3MBTL3 Q96JM7 6/20 0.46
L3MBTL1 Q9Y468 5/20 0.46
LMNA P02545 1/20 0.46
MBTD1 Q05BQ5 4/20 0.45
TP53BP1 Q12888 1/20 0.43
L3MBTL4 Q8NA19 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3404967 1.00 HRH3 (0.52) HRH3CNR1THRATHRBHTR2C
SCHEMBL3402358 0.91 CNR1 (0.50) HRH3CNR1THRATHRBHTR2C
SCHEMBL3405708 0.90 HRH3 (0.64) HRH3CNR1THRATHRBHTR2C
SCHEMBL13071533 0.90 HRH3 (0.64) HRH3CNR1THRATHRBHTR2C
SCHEMBL13071719 0.89 HRH3 (0.53) HRH3CNR1THRATHRBHTR2C
SCHEMBL3398438 0.89 HRH3 (0.53) HRH3CNR1THRATHRBHTR2C
SCHEMBL3405789 0.88 HRH3 (0.51) HRH3CNR1THRATHRBHTR2C
SCHEMBL3401167 0.88 HRH3 (0.51) HRH3CNR1THRATHRBHTR2C
SCHEMBL3400035 0.88 L3MBTL1 (0.57) HRH3CNR1THRATHRBHTR2C
SCHEMBL13071534 0.88 L3MBTL1 (0.57) HRH3CNR1THRATHRBHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed
US-7728009-B1 Thiazole amides, imidazole amides and related analogues NEUROGEN CORPORATION (US) 2010-06-01 US disclosed